Jun 15, 2020
Mymee Appoints Melinda Decker as Chief Commercial Officer
Jun 04, 2020
Artax Biopharma Announces Series B Financing Extension to Advance First-in-Class Autoimmune Disease Therapy
May 18, 2020
Oculis Reports Positive Top-line Data From SKYGGN (Phase 2) Trial With OCS-01 for Treating Inflammation and Pain Following Cataract Surgery
May 06, 2020
Foundation for Sarcoidosis Research and University of Cincinnati Share Initial Results of COVID-19 Impact Survey
Apr 30, 2020
Eiger BioPharmaceuticals Announces First COVID-19 Patients Dosed with Peginterferon Lambda
Apr 10, 2020
Early Impacts of COVID-19 on Autoimmune Disease Diagnosis Market - Exclusive Report by MarketsandMarkets(TM)
Jan 17, 2020
AMPEL BioSolutions Announces Gene-Based Lupus Diagnostic At Biotech Showcase In San Francisco
Jan 10, 2020
Mymee Relaunches Website to Support Patient-Centric Approach to Autoimmune Disease
Nov 19, 2019
Forward Science And The TeleDentists Announce A SalivaMAX Sponsorship Agreement
Nov 08, 2019
Global $18 Billion Autoimmune Disease Diagnostic Markets to 2026
Nov 06, 2019
Viracta Announces Oral Presentation on Lead Program for EBV-associated Lymphomas at the 2019 American Society of Hematology (ASH) Annual Meeting
Oct 24, 2019
Lupus Research Alliance Announces 2019 Distinguished Innovator Awards Aimed at New Lupus Treatments
Oct 21, 2019
Sjogren's Syndrome (SS) Market Insights, Epidemiology and Market Forecast, 2028
Aug 28, 2019
Salimetrics and daacro Celebrate 5 Years of Salivary Bioscience Excellence
Aug 15, 2019
Cincinnati Sarcoidosis Education Conference to Take Place August 24, 2019
Jul 19, 2019
International Lupus Community Reaches First-Ever Agreement on Barriers to Research, Drug Development, Care and Access
Jun 13, 2019
VALUE Study Results Show Custom Mobile App Lets Patients Accurately Report Response to Treatment
Jun 06, 2019
Mymee, Inc. Expands Executive Leadership Team to Support Commercial Growth
Jun 03, 2019
Viracta Presents New Clinical Results on Lead Epigenetic Drug Candidate for EBV-Associated Lymphomas at the 2019 ASCO Annual Meeting
May 29, 2019
New Study Partly Funded by the Lupus Research Alliance Reveals Novel Lupus Drug Targets